AcuFocus, Inc. is an ophthalmic medical device company that develops breakthrough small aperture intraocular technology to address diverse unmet needs in eye care. The company is known for the KAMRA corneal inlay for presbyopia and the IC-8 Apthera intraocular lens (IOL), a small aperture, non-toric extended depth of focus lens approved by the U.S. FDA in July 2022 for certain cataract patients with corneal astigmatism who wish to address presbyopia. The IC-8 IOL received CE mark in 2015 and is available across select markets in Europe, Australia, New Zealand and Singapore. Headquartered in Irvine, California, AcuFocus was acquired by Bausch + Lomb in January 2023.
AcuFocus has been acquired
This company is no longer available on our private secondary market.
Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Founded
2001
Employees
51–200
Total Funding
$203.89M
9 rounds
Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Total raised $203.89M across 9 rounds
Last updated 09-23-2026
| Date | Round | Amount Raised | Valuation | Lead Investors |
|---|---|---|---|---|
| Aug 8, 2018 | Late-stage venture financing | $23.97M | — | Not disclosed |
| Sep 9, 2016 | Growth financing (KKR-led) Press release | $66M | — | KKR |
| Aug 10, 2016 | Debt financing | $2M | — | Not disclosed |
Access live market data
Sign UpData collected with AI, which can make mistakes. Please double-check this information.